The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessAbstract
Primary cutaneous lymphomas (PCLs) are defined as non-Hodgkin lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis. After gastrointestinal lymphomas, PCLs are the second most common group of extranodal non-Hodgkin lymphomas, with an estimated annual incidence of 1/100 000 in Western countries. PCLs must be distinguished from nodal or systemic malignant lymphomas involving the skin secondarily, which often have another clinical behaviour, have a different prognosis and require a different therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
WHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
Self-citationOlsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., Zackheim, H., Duvic, M., Estrach, T., Lamberg, S., et al. (2007) · Blood · doi:10.1182/blood-2007-03-055749 · Cited by 1,429
Self-citationOlsen, E. A., Kim, Y. H., Kuzel, T. M., Pacheco, T. R., Foss, F. M., Parker, S., Frankel, S. R., Chen, C., Ricker, J. L., Arduino, J. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2434 · Cited by 1,055
Agar, N. S., Wedgeworth, E., Crichton, S., Mitchell, T. J., Cox, M., Ferreira, S., Robson, A., Calonje, E., Stefanato, C. M., Wain, E. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.7665 · Cited by 853
Bekkenk, M. W., Geelen, F. A. M. J., Vader, P. C. V. V., Heule, F., Geerts, M.-L., van Vloten, W. A., Meijer, C. J. L. M., & Willemze, R. (2000) · Blood · doi:10.1182/blood.v95.12.3653 · Cited by 800
Self-citationOlsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., Wood, G. S., Willemze, R., Demierre, M.-F., Pimpinelli, N., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0630 · Cited by 666
Self-citationWhittaker, S. J., Demierre, M.-F., Kim, E. J., Rook, A. H., Lerner, A., Duvic, M., Scarisbrick, J., Reddy, S., Robak, T., Becker, J. C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9066 · Cited by 664
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Prince, H. M., Kim, Y. H., Horwitz, S. M., Dummer, R., Scarisbrick, J., Quaglino, P., Zinzani, P. L., Wolter, P., Sanches, J. A., Ortiz-Romero, P. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31266-7 · Cited by 588
Self-citationKim, Y. H., Willemze, R., Pimpinelli, N., Whittaker, S., Olsen, E. A., Ranki, A., Dummer, R., & Hoppe, R. T. (2007) · Blood · doi:10.1182/blood-2006-10-054601 · Cited by 489
Self-citationKaye, F. J., Bunn, P. A., Steinberg, S. M., Stocker, J. L., Ihde, D. C., Fischmann, A. B., Glatstein, E. J., Schechter, G. P., Phelps, R. M., Foss, F. M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212603 · Cited by 487
Trautinger, F., Eder, J., Assaf, C., Bagot, M., Cozzio, A., Dummer, R., Gniadecki, R., Klemke, C.-D., Ortiz-Romero, P. L., Papadavid, E., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.027 · Cited by 452
Self-citationSenff, N. J., Noordijk, E. M., Kim, Y. H., Bagot, M., Berti, E., Cerroni, L., Dummer, R., Duvic, M., Hoppe, R. T., Pimpinelli, N., et al. (2008) · Blood · doi:10.1182/blood-2008-04-152850 · Cited by 450
Self-citationScarisbrick, J. J., Prince, H. M., Vermeer, M. H., Quaglino, P., Horwitz, S., Porcu, P., Stadler, R., Wood, G. S., Beylot-Barry, M., Pham-Ledard, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.7142 · Cited by 430
Self-citationKempf, W., Pfaltz, K., Vermeer, M. H., Cozzio, A., Ortiz-Romero, P. L., Bagot, M., Olsen, E., Kim, Y. H., Dummer, R., Pimpinelli, N., et al. (2011) · Blood · doi:10.1182/blood-2011-05-351346 · Cited by 423
Self-citationOgura, M., Ishida, T., Hatake, K., Taniwaki, M., Ando, K., Tobinai, K., Fujimoto, K., Yamamoto, K., Miyamoto, T., Uike, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.0924 · Cited by 362
Duvic, M., Tetzlaff, M. T., Gangar, P., Clos, A. L., Sui, D., & Talpur, R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.3787 · Cited by 299
Kim, Y. H., Tavallaee, M., Sundram, U., Salva, K. A., Wood, G. S., Li, S., Rozati, S., Nagpal, S., Krathen, M., Reddy, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.3969 · Cited by 282
How I treat mycosis fungoides and Sézary syndrome
Whittaker, S., Hoppe, R., & Prince, H. M. (2016) · Blood · doi:10.1182/blood-2015-12-611830 · Cited by 238
Prince, H. M., Duvic, M., Martin, A., Sterry, W., Assaf, C., Sun, Y., Straus, D., Acosta, M., & Negro-Vilar, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2386 · Cited by 233
Duvic, M., Pinter-Brown, L. C., Foss, F. M., Sokol, L., Jorgensen, J. L., Challagundla, P., Dwyer, K. M., Zhang, X., Kurman, M. R., Ballerini, R., et al. (2015) · Blood · doi:10.1182/blood-2014-09-600924 · Cited by 230
Specht, L., Dabaja, B., Illidge, T., Wilson, L. D., & Hoppe, R. T. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.008 · Cited by 227 · cited 5×
“Recommended radiation doses for localised PCMZL and PCFCL are 24–30 Gy [IV, A], whereas for palliative treatment of multifocal disease, low-dose RT (4 Gy) is often sufficient [III, A] [17, 18].”
BackgroundInfluentialSelf-citationHughes, C. F. M., Khot, A., McCormack, C., Lade, S., Westerman, D. A., Twigger, R., Buelens, O., Newland, K., Tam, C., Dickinson, M., et al. (2015) · Blood · doi:10.1182/blood-2014-07-588236 · Cited by 226
Hoppe, R. T., Harrison, C., Tavallaee, M., Bashey, S., Sundram, U., Li, S., Million, L., Dabaja, B., Gangar, P., Duvic, M., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.10.014 · Cited by 202
Lessin, S. R., Duvic, M. A., Guitart, J., Pandya, A. G., Strober, B. E., Olsen, E. A., Hull, C. M., Knobler, E. H., Rook, A. H., Kim, E. J., et al. (2012) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.541 · Cited by 192
Bernengo, M. G., Quaglino, P., Comessatti, A., Ortoncelli, M., Novelli, M., Lisa, F., & Fierro, M. T. (2007) · Haematologica · doi:10.3324/haematol.11127 · Cited by 174
Low-Dose Palliative Radiotherapy for Cutaneous B- and T-Cell Lymphomas
Neelis, K. J., Schimmel, E. C., Vermeer, M. H., Senff, N. J., Willemze, R., & Noordijk, E. M. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.06.1918 · Cited by 172
Self-citationGemcitabine as frontline treatment for cutaneous T‐cell lymphoma: Phase II study of 32 patients
Marchi, E., Alinari, L., Tani, M., Stefoni, V., Pimpinelli, N., Berti, E., Pagano, L., Bernengo, M. G., Zaja, F., Rupoli, S., et al. (2005) · Cancer · doi:10.1002/cncr.21449 · Cited by 161
Self-citationQuaglino, P., Maule, M. M., Prince, H. M., Porcu, P., Horwitz, S. M., Duvic, M. A., Talpur, R., Vermeer, M. H., Bagot, M., Guitart, J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx352 · Cited by 140
Self-citationMehta, N., Wayne, A. S., Kim, Y. H., Hale, G. A., Alvarado, C. S., Myskowski, P. L., Jaffe, E. S., BUSAM, K. J., Pulitzer, M. P., Zwerner, J. P., et al. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.06.016 · Cited by 78
Russell‐Jones, R. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03286.x · Cited by 59
Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to Treatment
Violetti, S. A., Talpur, R., Schlichte, M. J., Sui, D., & Duvic, M. A. (2015) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2015.02.027 · Cited by 53
Melchers, R. C., Willemze, R., Daniels, L. A., Neelis, K. J., Bekkenk, M. W., de Haas, E. R. M., Horváth, B., van Rossum, M. M., Sanders, C. J. G., Velstra, B., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.08.010 · Cited by 30
Self-citationMelchers, R. C., Willemze, R., Bekkenk, M. W., de Haas, E. R. M., Horváth, B., van Rossum, M. M., Sanders, C. J. G., Veraart, J. C. J. M., Vermeer, M. H., & Quint, K. D. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16501 · Cited by 24
Self-citation
Cited by
Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
Strehl, C., Ehlers, L., Gaber, T., & Buttgereit, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01744 · Cited by 308
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
Hodak, E., Geskin, L., Guenova, E., Ortiz-Romero, P. L., Willemze, R., Zheng, J., Cowan, R., Foss, F., Mangas, C., & Querfeld, C. (2023) · American Journal of Clinical Dermatology · doi:10.1007/s40257-022-00732-w · Cited by 47
Self-citationZhao, J., Bai, J., Li, G., Sun, Q., Li, S., Wang, C., Li, H., Xue, R., & Qiao, J. (2026) · British Journal of Dermatology · doi:10.1093/bjd/ljag129 · Cited by 2
Metadata
- Authors
- Willemze, R., Hodak, E., Zinzani, P. L., Specht, L., & Ladetto, M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Pages
- iv30-iv40
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4251706010
- Cited by
- 281
- References
- 36
- FWCI
- 23.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.